Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure supports the creation of receptor modulators due to the presence of a morpholine ring and a halogenated benzyl group, which enhance binding affinity and metabolic stability. Commonly employed in medicinal chemistry for constructing small molecule libraries in drug discovery. Also utilized in the preparation of selective enzyme inhibitors and receptor agonists/antagonists in research settings.